Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation

Figure 2 Insulin resistance, hepatic steatosis, spleen size, severity of psoriasis, and disease age of psoriatic patients. A: Prediction of insulin resistance on severity of psoriasis; B: Prediction of hepatic steatosis (HS) on severity of psoriasis; C: Prediction of SLD on severity of psoriasis; D: Prediction of disease age of psoriatic patients on SLD. Dotted lines near the regression line are the 95% confidence curves, the far ones are the 95% prediction curves. HOMA: Homeostatic metabolic assessment; PASI: Psoriasis area and severity index; SLD: Spleen longitudinal diameter.